Compare $VCEL vs $VIR | Chartloom

Compare

$VCEL vs $VIR

Vericel Corp · Vir Biotechnology Inc

VCEL

Vericel Corp

VIR

Vir Biotechnology Inc

Compare $VCEL vs $VIR

Comparing Vericel Corp and Vir Biotechnology Inc

VCELVericel Corp

VIRVir Biotechnology Inc

VCELVericel Corp

Market cap

$2.05B

P/E (TTM)

86.61x

Forward P/E (NTM)

55.49x

Forward P/S (NTM)

5.56x

Rev growth (TTM)

23.0%

YTD performance

12.6%

52W performance

17.5%

FCF yield

3.0%

VIRVir Biotechnology Inc

Market cap

$1.97B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

36.09x

Rev growth (TTM)

1496.1%

YTD performance

97.0%

52W performance

93.4%

FCF yield

-10.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VCEL

VIR

Detailed metrics comparison

VCEL

Vericel Corp

VIR

Vir Biotechnology Inc

Market Cap

VCEL$2.05B

VIR$1.97B

Enterprise Value

VCEL$1.92B

VIR$1.69B

Price

VCEL$40.10

VIR$11.70

P/E Ratio

VCEL86.61x

VIRN/A

P/S Ratio

VCEL6.69x

VIR6.51x

EV/Sales

VCEL6.28x

VIR5.59x

EV/EBITDA

VCEL58.45x

VIR1.92x

P/B Ratio

VCEL5.56x

VIR1.92x

P/FCF Ratio

VCEL33.21x

VIRN/A

EV/FCF

VCEL31.19x

VIR-8.32x

PEG Ratio

VCEL0.32x

VIRN/A

Forward P/E (NTM)

VCEL55.49x

VIRN/A

Forward P/S (NTM)

VCEL5.56x

VIR36.09x

Revenue (TTM)

VCEL$306M

VIR$303M

Revenue Growth (YoY)

VCEL23.0%

VIR1496.1%

Forward Rev Growth

VCEL16.9%

VIR-58.9%

Gross Margin (TTM)

VCEL74.6%

VIR100.0%

Operating Margin (TTM)

VCEL6.0%

VIR0.0%

EBITDA Margin (TTM)

VCEL10.2%

VIR-45.9%

Net Margin (TTM)

VCEL7.9%

VIR-41.5%

FCF Margin (TTM)

VCEL20.1%

VIR-67.1%

Net Income (TTM)

VCEL$24M

VIR$-126M

FCF (TTM)

VCEL$62M

VIR$-204M

EPS (TTM)

VCEL$0.46

VIR-$0.75

ROE (TTM)

VCEL6.9%

VIR-1486.0%

ROA (TTM)

VCEL5.0%

VIR-1168.0%

ROIC (TTM)

VCEL6.9%

VIR-1486.0%

Cash

VCEL$125M

VIR$279M

Debt

VCEL$596K

VIR$0

Net Cash/Debt

VCEL$125M

VIR$279M

Current Ratio (TTM)

VCEL5.04x

VIR6.04x

Quick Ratio (TTM)

VCEL4.69x

VIR5.69x

Debt/Equity (TTM)

VCEL0.00x

VIR0.00x

Debt/Assets (TTM)

VCEL0.0%

VIR0.0%

Interest Coverage (TTM)

VCELN/A

VIRN/A

Net Debt/EBITDA (TTM)

VCEL0.00x

VIR0.00x

Beta

VCEL1.06

VIR1.77

52W Performance

VCEL17.5%

VIR93.4%

YTD Performance

VCEL12.6%

VIR97.0%

% from 52W High

VCEL-18.7%

VIR-2.6%

% from 52W Low

VCEL38.5%

VIR143.0%

Asset Turnover (TTM)

VCEL0.63x

VIR0.28x

FCF Yield (TTM)

VCEL3.0%

VIR-10.3%

Earnings Yield (TTM)

VCEL1.2%

VIR-6.4%

Dividend Yield (TTM)

VCELN/A

VIRN/A

Rule of 40

VCEL43.1

VIR1,428.9

EV/GP/RG

VCEL0.39

VIRN/A

Ticker research

View VCEL research View VIR research

Metric	VCEL Vericel Corp	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$2.05B	$1.97B
Enterprise Value	$1.92B	$1.69B
Price	$40.10	$11.70
P/E Ratio	86.61x	N/A
P/S Ratio	6.69x	6.51x
EV/Sales	6.28x	5.59x
EV/EBITDA	58.45x	1.92x
P/B Ratio	5.56x	1.92x
P/FCF Ratio	33.21x	N/A
EV/FCF	31.19x	-8.32x
PEG Ratio	0.32x	N/A
Forward P/E (NTM)	55.49x	N/A
Forward P/S (NTM)	5.56x	36.09x
Revenue & Growth
Revenue (TTM)	$306M	$303M
Revenue Growth (YoY)	23.0%	1496.1%
Forward Rev Growth	16.9%	-58.9%
Profitability
Gross Margin (TTM)	74.6%	100.0%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.2%	-45.9%
Net Margin (TTM)	7.9%	-41.5%
FCF Margin (TTM)	20.1%	-67.1%
Net Income (TTM)	$24M	$-126M
FCF (TTM)	$62M	$-204M
EPS (TTM)	$0.46	-$0.75
ROE (TTM)	6.9%	-1486.0%
ROA (TTM)	5.0%	-1168.0%
ROIC (TTM)	6.9%	-1486.0%
Financial Health
Cash	$125M	$279M
Debt	$596K	$0
Net Cash/Debt	$125M	$279M
Current Ratio (TTM)	5.04x	6.04x
Quick Ratio (TTM)	4.69x	5.69x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.77
52W Performance	17.5%	93.4%
YTD Performance	12.6%	97.0%
% from 52W High	-18.7%	-2.6%
% from 52W Low	38.5%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.28x
FCF Yield (TTM)	3.0%	-10.3%
Earnings Yield (TTM)	1.2%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.1	1,428.9
EV/GP/RG	0.39	N/A
Ticker research	View VCEL research	View VIR research

Valuation

P/E Ratio

VCEL

86.61x

P/S Ratio

VIR

6.51x

VCEL

6.69x

EV/FCF

VIR

-8.32x

VCEL

31.19x

Growth & revenue

Revenue Growth TTM

VIR

1496.1%

VCEL

23.0%

Forward Revenue Growth

VCEL

16.9%

VIR

-58.9%

Profitability & performance

Gross Margin

VIR

100.0%

VCEL

74.6%

ROE

VCEL

6.9%

VIR

-1486.0%

FCF Yield %

VCEL

3.0%

VIR

-10.3%

52-Week Performance

VIR

93.4%

VCEL

17.5%

Detailed metrics comparison

VCEL

Vericel Corp

VIR

Vir Biotechnology Inc

Market Cap

VCEL$2.05B

VIR$1.97B

Enterprise Value

VCEL$1.92B

VIR$1.69B

Price

VCEL$40.10

VIR$11.70

P/E Ratio

VCEL86.61x

VIRN/A

P/S Ratio

VCEL6.69x

VIR6.51x

EV/Sales

VCEL6.28x

VIR5.59x

EV/EBITDA

VCEL58.45x

VIR1.92x

P/B Ratio

VCEL5.56x

VIR1.92x

P/FCF Ratio

VCEL33.21x

VIRN/A

EV/FCF

VCEL31.19x

VIR-8.32x

PEG Ratio

VCEL0.32x

VIRN/A

Forward P/E (NTM)

VCEL55.49x

VIRN/A

Forward P/S (NTM)

VCEL5.56x

VIR36.09x

Revenue (TTM)

VCEL$306M

VIR$303M

Revenue Growth (YoY)

VCEL23.0%

VIR1496.1%

Forward Rev Growth

VCEL16.9%

VIR-58.9%

Gross Margin (TTM)

VCEL74.6%

VIR100.0%

Operating Margin (TTM)

VCEL6.0%

VIR0.0%

EBITDA Margin (TTM)

VCEL10.2%

VIR-45.9%

Net Margin (TTM)

VCEL7.9%

VIR-41.5%

FCF Margin (TTM)

VCEL20.1%

VIR-67.1%

Net Income (TTM)

VCEL$24M

VIR$-126M

FCF (TTM)

VCEL$62M

VIR$-204M

EPS (TTM)

VCEL$0.46

VIR-$0.75

ROE (TTM)

VCEL6.9%

VIR-1486.0%

ROA (TTM)

VCEL5.0%

VIR-1168.0%

ROIC (TTM)

VCEL6.9%

VIR-1486.0%

Cash

VCEL$125M

VIR$279M

Debt

VCEL$596K

VIR$0

Net Cash/Debt

VCEL$125M

VIR$279M

Current Ratio (TTM)

VCEL5.04x

VIR6.04x

Quick Ratio (TTM)

VCEL4.69x

VIR5.69x

Debt/Equity (TTM)

VCEL0.00x

VIR0.00x

Debt/Assets (TTM)

VCEL0.0%

VIR0.0%

Interest Coverage (TTM)

VCELN/A

VIRN/A

Net Debt/EBITDA (TTM)

VCEL0.00x

VIR0.00x

Beta

VCEL1.06

VIR1.77

52W Performance

VCEL17.5%

VIR93.4%

YTD Performance

VCEL12.6%

VIR97.0%

% from 52W High

VCEL-18.7%

VIR-2.6%

% from 52W Low

VCEL38.5%

VIR143.0%

Asset Turnover (TTM)

VCEL0.63x

VIR0.28x

FCF Yield (TTM)

VCEL3.0%

VIR-10.3%

Earnings Yield (TTM)

VCEL1.2%

VIR-6.4%

Dividend Yield (TTM)

VCELN/A

VIRN/A

Rule of 40

VCEL43.1

VIR1,428.9

EV/GP/RG

VCEL0.39

VIRN/A

Ticker research

View VCEL research View VIR research

Metric	VCEL Vericel Corp	VIR Vir Biotechnology Inc
Market & Valuation
Market Cap	$2.05B	$1.97B
Enterprise Value	$1.92B	$1.69B
Price	$40.10	$11.70
P/E Ratio	86.61x	N/A
P/S Ratio	6.69x	6.51x
EV/Sales	6.28x	5.59x
EV/EBITDA	58.45x	1.92x
P/B Ratio	5.56x	1.92x
P/FCF Ratio	33.21x	N/A
EV/FCF	31.19x	-8.32x
PEG Ratio	0.32x	N/A
Forward P/E (NTM)	55.49x	N/A
Forward P/S (NTM)	5.56x	36.09x
Revenue & Growth
Revenue (TTM)	$306M	$303M
Revenue Growth (YoY)	23.0%	1496.1%
Forward Rev Growth	16.9%	-58.9%
Profitability
Gross Margin (TTM)	74.6%	100.0%
Operating Margin (TTM)	6.0%	0.0%
EBITDA Margin (TTM)	10.2%	-45.9%
Net Margin (TTM)	7.9%	-41.5%
FCF Margin (TTM)	20.1%	-67.1%
Net Income (TTM)	$24M	$-126M
FCF (TTM)	$62M	$-204M
EPS (TTM)	$0.46	-$0.75
ROE (TTM)	6.9%	-1486.0%
ROA (TTM)	5.0%	-1168.0%
ROIC (TTM)	6.9%	-1486.0%
Financial Health
Cash	$125M	$279M
Debt	$596K	$0
Net Cash/Debt	$125M	$279M
Current Ratio (TTM)	5.04x	6.04x
Quick Ratio (TTM)	4.69x	5.69x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.06	1.77
52W Performance	17.5%	93.4%
YTD Performance	12.6%	97.0%
% from 52W High	-18.7%	-2.6%
% from 52W Low	38.5%	143.0%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.28x
FCF Yield (TTM)	3.0%	-10.3%
Earnings Yield (TTM)	1.2%	-6.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	43.1	1,428.9
EV/GP/RG	0.39	N/A
Ticker research	View VCEL research	View VIR research